2.00Open2.00Pre Close0 Volume0 Open Interest7.00Strike Price0.00Turnover153.03%IV-4.60%PremiumJul 19, 2024Expiry Date2.22Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9759Delta0.0737Gamma2.15Leverage Ratio-0.0033Theta-0.0005Rho-2.10Eff Leverage0.0003Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet